Contributor:

Nancy Holekamp MD

COVID-19: How COVID-19 Affects US Retina Practices

John Kitchens, MD; Sunir Garg, MD; Nancy Holekamp, MD; and Rishi Singh, MD

Preventing Vitreous Liquefaction

Nancy Holekamp, MD, Ranna Jaraha

Changing Treatment Paradigms for DR: Reviewing the Data

Arshad M. Khanani, MD, Nancy Holekamp, MD

Reviewing the BOULEVARD Trial and RG7716

Arshad M. Khanani, MD, Nancy Holekamp, MD, Rishi P. Singh, MD

Translating Data for Educating Patients With DR

Arshad M. Khanani, MD, Nancy Holekamp, MD, Rishi P. Singh, MD

Think Outside the Box: Treatment Options for DR

Arshad M. Khanani, MD, Nancy Holekamp, MD, Rishi P. Singh, MD

Anti-VEGF for DR: Implications for Clinical Practice

Arshad M. Khanani, MD, Nancy Holekamp, MD

A Provocative AMD Case

Nancy Holekamp, MD

Women in Retina

Anne E. Fung, MD, Jennifer I. Lim, MD, Nancy M. Holekamp, MD

How to Deploy Home OCT

Nancy M. Holekamp, MD

Are You Ready to Become a Clinical Trialist?

Basil K. Williams Jr, MD; and Nancy M. Holekamp, MD

ARCHWAY at AAO

Nancy Holekamp, MD

ASRS 2021 Coverage: The Pipeline for Wet AMD and GA

Mark Barakat, MD; and Nancy Holekamp, MD